China Medical Technologies
China Medical Technologies, Inc. (NASDAQ:CMED) is a China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic ("IVD") products using enhanced chemiluminescence ("ECLIA") technology, fluorescent in-situ hybridization ("FISH") technology and surface plasmon resonance (“SPR”) technology to detect and monitor various diseases and disorders. In February 2012, the company's shares moved from the NASDAQ to the pink sheet in the United States. The company is in default due to failure to pay interest to bondholders.
Wikipage redirect
primaryTopic
China Medical Technologies
China Medical Technologies, Inc. (NASDAQ:CMED) is a China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic ("IVD") products using enhanced chemiluminescence ("ECLIA") technology, fluorescent in-situ hybridization ("FISH") technology and surface plasmon resonance (“SPR”) technology to detect and monitor various diseases and disorders. In February 2012, the company's shares moved from the NASDAQ to the pink sheet in the United States. The company is in default due to failure to pay interest to bondholders.
has abstract
China Medical Technologies, In ...... o pay interest to bondholders.
@en
foundation place
industry
key person
number of employees
product
revenue ($)
type
Link from a Wikipage to an external page
Wikipage page ID
11,332,371
Wikipage revision ID
721,355,089
net profit
comment
China Medical Technologies, In ...... o pay interest to bondholders.
@en
label
China Medical Technologies
@en
wasDerivedFrom
homepage
isPrimaryTopicOf
name
China Medical Technologies Inc.
@en